Roche, Lilly push back against CMS painting their Alzheimer’s meds with the same brush as Biogen’s Aduhelm
Roche, Lilly push back against CMS painting their Alzheimer’s meds [...]
ProQR shares plummet as eye disease treatment flops phase 2/3 pediatric trial
ProQR shares plummet as eye disease treatment flops phase 2/3 [...]
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer’s drug trials
Cassava scores a win as FDA declines to intervene in [...]
Metacrine lays off half its staff, mainly researchers, and ditches more work to focus on IBD after NASH disaster
Metacrine lays off half its staff, mainly researchers, and ditches [...]
Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund
Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund [...]
With approval in sight, ObsEva sells regional rights to women’s health drug for tiny upfront
With approval in sight, ObsEva sells regional rights to women’s [...]
Vivocore combines InterVivo, Transpharmation to form neuroscience CRO with an interest in psilocybin
Vivocore combines InterVivo, Transpharmation to form neuroscience CRO with an [...]
Curevo will go head-to-head against GSK’s Shingrix thanks to new $60M financing
Curevo will go head-to-head against GSK’s Shingrix thanks to new [...]
FDA denies Ardelyx’s appeal against kidney drug rejection, hammering another nail in tenapanor’s coffin
FDA denies Ardelyx’s appeal against kidney drug rejection, hammering another [...]
AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world
AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a [...]